Study of celiac disease antibodies and IgG4 antibody in inflammatory bowel disease

Study of celiac disease antibodies and IgG4 antibody in inflammatory bowel disease - Study of celiac disease antibodies and IgG4 antibody in IBD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022674

Enrollment

300

Registered

2016-06-10

Start date

2016-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Inflammatory bowel disease

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
anti-gliadin IgG, anti-gliadin IgA,anti-tissue transglutaminase IgG,anti-tissue transglutaminase IgA,anti-deamidated gliadin peptide IgA,anti-deamidated gliadin peptide IgG,IgG4 antibody	—

Countries

Japan

Contacts

Public ContactManabu Ishii

Kawasaki Medical School Gastroenterology Department of Internal Medicine

manabuisii@niji.or.jp086-462-1111

Outcome results